Open AccessDoes perioperative use of aprotinin reduce the rejection rate in heart transplant recipients?☆
Author(s) -
Jeffrey Shuhaiber,
Kimberley Goldsmith,
Stephen Large,
Steven Tsui
Publication year - 2008
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2008.01.059
Subject(s) - tranexamic acid , aprotinin , medicine , antifibrinolytic , perioperative , anesthesia , surgery , heart transplantation , transplantation , blood loss
Allograft rejection continues to be one of the most common causes of mortality after heart transplantation. We investigated if perioperative use of antifibrinolytics such as aprotinin and tranexamic acid can decrease the rate of rejection after heart transplant and their effect on transfusion.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom